Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-109497·FARADAY FUTURE INTELLIGENT ELECTRIC INC.
Schedule 13D ownership disclosure
Qualigen Therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 74754R103
Event date: 2025-11-06
- Filing-level shares
- 248,722.00
- Percent of class
- 8.0%
- FARADAY FUTURE INTELLIGENT ELECTRIC INC.Reported CIK 0001805521
Shares: 248,722.00 · Class: 8.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-109497
- Form type
- SCHEDULE 13D
- Filer
- FARADAY FUTURE INTELLIGENT ELECTRIC INC.
- CIK
- CIK 1805521
- Filed
- Nov 12, 2025
- Reporting period
- Nov 06, 2025
- Description
- Schedule 13D beneficial ownership